Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Intelligent Protection Management Signs $2.7M M&A Deal with Advanced Technology Distributors Inc.
Intelligent Protection Management Corp. (IPM) has entered into a definitive agreement to acquire the managed services business of Advanced Technology Distributors Inc. (AdTech) for up to $2.7 million. The transaction is structured in two stages, with IPM initially acquiring a 49% stake in a newly formed subsidiary (JVCo) followed by the remaining 51% upon receiving regulatory approvals from the California Public Utilities Commission. The deal aims to expand IPM's managed technology solutions and cybersecurity capabilities into the California market.
Tango Therapeutics announced updated Phase 1/2 clinical trial results for vopimetostat in combination with daraxonrasib, showing an 82% objective response rate in patients with MTAP-deleted and RAS-mutant pancreatic cancer. The data demonstrated a 9-month progression-free survival rate of 88%, leading the company to plan a registrational Phase 3 trial in the first half of 2027.
Ftai Infrastructure Signs $255M M&A Deal with DRUbit LLC
FTAI Infrastructure's subsidiary Jefferson is providing a status update on its $255 million acquisition of DRUbit LLC from US Development Group. Jefferson plans to incur $270 million in new debt to fund the deal and expects the acquired assets to contribute $50 million in annual Adjusted EBITDA, effectively doubling Jefferson's total annual Adjusted EBITDA to approximately $100 million.
Zymeworks entered into a global collaboration and license agreement with Roche for the development and commercialization of ZW209, a trispecific T-cell engager targeting DLL3. Zymeworks will receive a $55 million upfront payment and a $40 million milestone upon Phase 1b trial initiation, with eligibility for up to $718 million in additional milestones plus tiered royalties.
Zai Lab Limited entered into a securities purchase agreement with accredited investors for a private placement (PIPE) of 11,340,000 American depositary shares (ADSs). The company expects to receive gross proceeds of approximately $250 million to fund pipeline development and general corporate purposes. The ADSs are priced at $22.04 each, and the company has agreed to file a registration statement for the resale of these securities.
S&P Global Inc. provided pro forma financial statements following the completed spin-off of its S&P Global Mobility segment into an independent public company, Mobility Global Inc. (NYSE: MBGL). The separation was executed via a pro rata distribution of one share of Mobility Global for every share of S&P Global held as of the June 15, 2026 record date.
Inflection Point Acquisition Corp. VI M&A Deal with Quantum Space, LLC
Inflection Point Acquisition Corp. VI entered into an amendment to its existing business combination agreement with Quantum Space, LLC. The amendment changes the intended listing exchange for the post-combination company from Nasdaq to the New York Stock Exchange (NYSE) and modifies the requirements for the post-closing board of directors composition.
Lunai Bioworks received a Nasdaq delisting determination for failing to maintain the minimum stockholders' equity requirement of $2.5 million, reporting a deficit of over $9 million. The company has decided not to appeal the decision and will voluntarily delist its common stock from Nasdaq and deregister with the SEC to save costs.
Black Hills M&A Deal with NorthWestern Energy Group, Inc.
Black Hills Corp. provided a status update on its pending merger with NorthWestern Energy, announcing that the combined entity will be renamed Bright Horizon Energy Corporation and trade under the ticker 'HZN' upon closing. The merger is currently awaiting final regulatory approval from the Montana Public Service Commission, which is expected to consider the deal by November 12, 2026.
Grown Rogue International announced its commercial entry into the Illinois cannabis market through its affiliate SEA Craft LLC, which completed its first product deliveries to select dispensaries. The launch follows the June 2026 restart of the Dwight cultivation facility, which currently operates 5,000 square feet of flowering canopy with plans to expand to 10,000 square feet.
Valor Energy Signs $3.6M M&A Deal with Glorious Star LLC
Valor Energy Inc. entered into a definitive agreement to acquire 100% of the equity interests of Glorious Star LLC (the Target Company) for an aggregate purchase price of $3.6 million. The Target Company holds site ownership and development rights for a computing center project in Youngstown, Ohio, featuring 18 MVA of power capacity and approximately 30,888 square feet of warehouse space. The deal is subject to a 30-business-day due diligence period and is expected to close shortly thereafter.
PAVmed's subsidiary, Lucid Diagnostics Inc., completed a private placement of 15,000 shares of Series C Convertible Preferred Stock to accredited investors. The offering generated gross proceeds of $15.0 million at a purchase price of $1,000 per share. Lucid Diagnostics also entered into a registration rights agreement to facilitate the resale of common stock issuable upon conversion of the preferred shares.
Frazier Life Sciences Acquisition Corp. II Capital Raise of $78M
Frazier Life Sciences Acquisition Corp. II completed its initial public offering of 7,500,000 Class A ordinary shares and a simultaneous private placement of 300,000 shares to its sponsor, generating total gross proceeds of $78 million. Of these proceeds, $75 million was deposited into a U.S.-based trust account for the benefit of public shareholders.
BranchOut Food Inc. has commenced an underwritten public offering of its common stock to fund operating plans and growth initiatives. Alongside the offering, the company provided a business update expecting record Q4 revenue of $6M–$7M and a recurring revenue base of approximately $4M per quarter heading into 2027.
NeOnc Technologies reported early clinical improvement in the first pediatric patient treated with its investigational intranasal NEO100 under a Compassionate Care program in Abu Dhabi. The company also announced a Memorandum of Understanding with the Department of Health – Abu Dhabi to cooperate on oncology and CNS therapeutic research.
DevvStream Legacy Corp. completed its business combination with XCF Global, Inc. on October 16, 2026, following its domestication as a Delaware corporation. Under the terms of the agreement, DevvStream shareholders received 1.1919 shares of XCF Class A common stock for each share held, resulting in the issuance of approximately 62.3 million XCF shares.
Disc Medicine closed an underwritten public offering of 6,000,000 shares of common stock at a price of $75.00 per share, generating gross proceeds of $450 million. The company expects the net proceeds to extend its cash runway into 2030, supporting the clinical development and potential commercialization of its hematologic disease treatments, including bitopertin.
XCF Global M&A Deal with Southern Energy Renewables Inc. and DevvStream Corp.
XCF Global, Inc. completed its previously announced all-stock business combination with Southern Energy Renewables and DevvStream Corp. on October 16, 2026. The transaction creates a vertically integrated alternative energy platform, with former Southern and DevvStream equity holders owning approximately 20.0% and 10.43% of the combined company, respectively.
Counterparty
Southern Energy Renewables Inc. and DevvStream Corp.
“Today marks an important milestone for XCF as we bring together renewable fuel production, new technology pathways and environmental-asset optimization capabilities on one vertically integrated platform. This combination expands our capabilities and supports our strategy to reduce emissions, enhance energy security and resilience, promote alternative uses for domestic agricultural resources, locate production closer to demand and pursue additional value across the alternative renewable fuels chain across our growing glob”
Chris Cooper, Chief Executive Officer of XCF Global
Atlantic American Corporation received a staff delisting determination from Nasdaq on October 16, 2026, due to its failure to timely file its 2025 Annual Report and two subsequent 2026 Quarterly Reports. The company has since filed its 2025 Form 10-K and intends to appeal the delisting notice by requesting a hearing before a Nasdaq Hearings Panel to stay the suspension of its common stock. The company is working to file the remaining delinquent reports to regain compliance with Nasdaq Listing Rule 5250(c)(1).
Tenon Medical entered into waivers with an institutional investor and its placement agent to permit an increase in the capacity of its existing 'at-the-market' (ATM) offering program. As consideration for the waiver, the company issued a new warrant to the investor for 125,000 shares of common stock at an exercise price of $5.02 per share.
Janel Signs $17M M&A Deal with EnCor Biotechnology Inc.
Janel Corporation, through its subsidiary Antibodies Incorporated, acquired 100% of EnCor Biotechnology Inc. for $17 million, consisting of $11.96 million in cash and a $5.04 million subordinated promissory note. The acquisition of the Florida-based biotechnology company was funded through cash on hand and an $11 million draw from an expanded senior credit facility.
Auddia Signs $3.31M M&A Deal with Thramann Holdings, LLC
Auddia Inc. amended its interim bridge funding agreements for the target companies involved in its pending merger with McCarthy Finney, Inc. and Thramann Holdings. The amendment increases the maximum aggregate funding available to the four target entities (Thramann Holdings, LT350, Influence Healthcare, and Voyex) to $3.305 million to provide working capital while the merger remains pending.
Lucid Diagnostics entered into subscription agreements with accredited investors for the private placement of 15,000 shares of newly designated Series C Convertible Preferred Stock. The offering generated aggregate gross proceeds of approximately $15.0 million at a purchase price of $1,000 per share.
ContextLogic Holdings Signs $850M M&A Deal with EagleTree-Gaylord Holdings Corp.
ContextLogic Holdings Inc. entered into an amendment to its existing $850 million acquisition agreement for EagleTree-Gaylord Holdings Corp. to increase the equity rollover amount from $2 million to $7 million. The company also provided a timeline update, now expecting the transaction to close in late 2026 or the first quarter of 2027.
Range Capital Acquisition Corp. drew down $60,000 from an existing unsecured promissory note with its sponsor to fund a monthly contribution to its trust account. This draw brings the total outstanding balance under the note to $300,000, which is intended to support the company's operations until it completes an initial business combination.
ARC Group Acquisition I Nasdaq/NYSE Compliance Notice
ARC Group Acquisition I Corp. received an extension from Nasdaq until February 23, 2027, to regain compliance with the $1 million minimum aggregate market value requirement for its warrants. The company expects to regain compliance by completing its previously announced business combination before the deadline. If compliance is not met by the extension date, the company's securities face potential delisting.
CitroTech Inc. closed an underwritten public offering of 2,240,000 shares of common stock at a price of $2.50 per share, generating gross proceeds of approximately $5.6 million. The company granted the underwriter a 45-day option to purchase an additional 336,000 shares and intends to use the net proceeds for working capital and general corporate purposes.
Net Power Inc. entered into an agreement with Saulsbury Industries to extend the deadline for delivering a full notice to proceed (FNTP) for its utility-scale project from October 2026 to March 31, 2027. The extension allows more time to negotiate a post-closing change order and a limited notice to proceed (LNTP) for the project's EPC agreement. If the company fails to execute the LNTP by November 15, 2026, it must pay a $3.5 million termination fee.
Alpha Modus Holdings entered into a securities purchase agreement with an institutional investor for a registered direct offering of 6,304,348 shares of Class A common stock. The offering is expected to generate gross proceeds of approximately $7.25 million, which the company intends to use for debt repayment and general corporate purposes.
Weave Communications M&A Deal with Francisco Partners
Stockholders of Weave Communications, Inc. approved the company's acquisition by affiliates of Francisco Partners at a special meeting held on October 22, 2026. Approximately 73% of the total outstanding shares voted in favor of adopting the merger agreement, satisfying the requisite stockholder approval for the transaction. Upon completion, Weave will become a wholly owned subsidiary of Willow Parent, LLC.